Albireo Pharma Statistics Share Statistics Albireo Pharma has 20.74M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 20.74M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 14.22M Failed to Deliver (FTD) Shares 675 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 150.39K, so 0% of the outstanding
shares have been sold short.
Short Interest 150.39K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -2.96 and the forward
PE ratio is null.
Albireo Pharma's PEG ratio is
-0.52.
PE Ratio -2.96 Forward PE n/a PS Ratio 11.03 Forward PS n/a PB Ratio 2.55 P/FCF Ratio -4.14 PEG Ratio -0.52
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Albireo Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.93,
with a Debt / Equity ratio of 0.06.
Current Ratio 5.93 Quick Ratio 5.93 Debt / Equity 0.06 Debt / EBITDA -0.5 Debt / FCF -0.09 Interest Coverage -8.86
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $312.15K Profits Per Employee $-1.16M Employee Count 130 Asset Turnover 0.13 Inventory Turnover 6.99
Taxes Income Tax 117.32M Effective Tax Rate -344.75%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.04, so Albireo Pharma's
price volatility has been higher than the market average.
Beta 1.04 52-Week Price Change n/a 50-Day Moving Average 37.97 200-Day Moving Average 25.15 Relative Strength Index (RSI) 68.03 Average Volume (20 Days) 566,901
Income Statement In the last 12 months, Albireo Pharma had revenue of 40.58M
and earned -151.35M
in profits. Earnings per share was -7.87.
Revenue 40.58M Gross Profit 39.22M Operating Income -123.48M Net Income -151.35M EBITDA -19.82M EBIT -20.1M Earnings Per Share (EPS) -7.87
Full Income Statement Balance Sheet The company has 248.11M in cash and 10M in
debt, giving a net cash position of 238.1M.
Cash & Cash Equivalents 248.11M Total Debt 10M Net Cash 238.1M Retained Earnings -300.85M Total Assets 321.22M Working Capital 201.02M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -107.56M
and capital expenditures -465K, giving a free cash flow of -108.02M.
Operating Cash Flow -107.56M Capital Expenditures -465K Free Cash Flow -108.02M FCF Per Share -5.62
Full Cash Flow Statement Margins Gross margin is 96.66%, with operating and profit margins of -304.31% and -372.97%.
Gross Margin 96.66% Operating Margin -304.31% Pretax Margin -83.86% Profit Margin -372.97% EBITDA Margin -48.85% EBIT Margin -304.31% FCF Margin -266.21%
Dividends & Yields ALBO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ALBO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 4, 2016. It was a
backward
split with a ratio of 1:30.
Last Split Date Nov 4, 2016 Split Type backward Split Ratio 1:30
Scores Altman Z-Score 0.52 Piotroski F-Score 4
